G&G Worldwide Ltd, in partnership with Oakmere Holdings, presents a healthcare investment opportunity focused on pioneering solutions in digital health, telemedicine, and AI-driven diagnostics. Guided by the ethical principles of Saudi Vision 2030, our mission is to enhance healthcare accessibility, patient care, and operational excellence across healthcare sectors.
Phil Gardiner, Chief Executive of Oakmere Holdings Group Ltd: With over 30 years of experience in healthcare and investment management, Phil has led large-scale projects and built successful investment strategies that align with ethical and cultural values.
Jerry Appleyard, Chief Executive of G&G Healthcare Fund: Jerry brings a wealth of knowledge in healthcare operations and investment, specializing in digital health and telemedicine initiatives. His leadership ensures that each project aligns with Saudi Vision 2030's goals and the fund's growth targets.
Finance Director: A veteran in financial strategy and analysis, the Finance Director oversees the fund's capital structure and investment due diligence, ensuring a balance between profitability and long-term sustainability.
Operations Director: With extensive experience in managing healthcare assets and facilities, the Operations Director ensures that projects are executed efficiently, with a focus on delivering high-quality healthcare solutions.
Together, the team combines a commitment to ethical investment with strategic insight, positioning the G&G Healthcare Fund as a leader in innovative healthcare investment.
The G&G Healthcare Fund focuses on high-impact healthcare sectors, including digital health platforms, AI diagnostics, telemedicine, and asset-backed healthcare facilities. Each project aligns with the fund’s mission to advance healthcare accessibility, patient care, and sustainable infrastructure.
Investors can expect a typical commitment of 5–10 years, with a thorough strategic review in year five. At that point, exit options such as asset sales or a public offering will be considered to optimize investor returns.
The fund aligns with Saudi Vision 2030 by prioritizing ethical investment practices, innovation in healthcare, and contributions to sustainable community development.
Yes, the fund operates within the highest regulatory standards in the UK, ensuring compliance with financial regulations and ethical guidelines.
The fund is guided by the principles of Saudi Vision 2030 and Islamic financial standards, ensuring all investments meet rigorous ethical guidelines. Our due diligence process prioritizes transparency, community impact, and sustainability, creating responsible growth opportunities.
The fund provides regular performance updates, including financial reports and project milestones. Additionally, investors have access to our team for any specific inquiries regarding portfolio growth and developments.
The fund is open to qualified investors who meet the minimum investment requirement of £100,000 and are looking for long-term, impactful opportunities in healthcare.
The fund employs a robust due diligence process, regular performance reviews, and strategic oversight to mitigate risks and maximize returns while maintaining ethical and operational excellence.
If you would like to discuss elements of the presentation or maybe you would like more information, please feel free to fill in the short form above and we will contact you imminently.
Thank you
Phil Gardiner
GGG Worldwide Ltd